Advertisement
UK markets closed

  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     

  • HANG SENG

    18,466.91
    -9.01 (-0.05%)
     

  • CRUDE OIL

    78.38
    +0.27 (+0.35%)
     

  • GOLD FUTURES

    2,317.50
    +8.90 (+0.39%)
     

  • DOW

    38,675.68
    +449.98 (+1.18%)
     

  • Bitcoin GBP

    50,937.43
    +475.08 (+0.94%)
     

  • CMC Crypto 200

    1,328.17
    +51.19 (+4.01%)
     

  • NASDAQ Composite

    16,156.33
    +315.33 (+1.99%)
     

  • UK FTSE All Share

    4,469.09
    +22.94 (+0.52%)
     
BRANDS:

Meet one of the UK’s largest unknown start-ups

Video editing platform Veed has grown to 10 million users

Canada competition bureau approves GlaxoSmithKline/Novartis deal

Reuters - UK Focus

OTTAWA, Feb 23 (Reuters) - Canada's Competition Bureau on Monday approved a deal between GlaxoSmithKline PLC (Other OTC: GLAXF - news) and Novartis AG (LSE: 0QLR.L - news) , noting in a statement that U.S. authorities had already said the transaction could go ahead.

The companies agreed last April to the transaction that includes GSK buying Novartis' vaccines business, Novartis purchasing GSK's cancer drugs, and the two groups tying up in consumer healthcare. (Reporting by David Ljunggren)